Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity

Dan Aravot, Yaron D. Barac, Efrat Krutzwald-Josefson, Aaron M. Allen, Dov Flex, Nir Peled, Mordechai R. Kramer, Yuri Peysakhovich, Milton Saute

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology